Intra-Cellular Therapies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	306.95	147.77	148.62	92.37	60.05
Short-Term Investments	694.12	350.17	443.29	319.97	597.4
Cash & Short-Term Investments	1,001	497.94	591.91	412.33	657.45
Cash Growth	101.04%	-15.88%	43.55%	-37.28%	193.49%
Accounts Receivable	166.5	114.02	75.19	20.16	10.76
Other Receivables	5	2.3	-	-	-
Receivables	171.5	116.32	75.19	20.16	10.76
Inventory	26.28	11.65	23.92	7.95	7.06
Prepaid Expenses	68.47	32.24	23.59	15.94	14.24
Restricted Cash	1.75	1.75	1.75	1.4	1.4
Other Current Assets	38.3	7.9	21.6	9.5	-
Total Current Assets	1,307	667.8	737.96	467.28	690.9
Property, Plant & Equipment	14.9	14.58	16.74	22.56	26.32
Other Long-Term Assets	44.65	45.91	0.09	0.09	0.09
Total Assets	1,367	728.3	754.78	489.92	717.31
Accounts Payable	26.07	11.45	10.4	8.69	5.5
Accrued Expenses	175.4	108.48	68.27	37.93	25.81
Current Portion of Leases	4.23	3.61	4.57	6.73	5.54
Total Current Liabilities	205.7	123.55	83.24	53.36	36.85
Long-Term Leases	12.75	13.33	15.47	18.68	23.6
Total Liabilities	218.45	136.87	98.71	72.03	60.45
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	2,840	2,208	2,138	1,639	1,593
Retained Earnings	-1,692	-1,617	-1,477	-1,221	-937.1
Comprehensive Income & Other	0.19	0.1	-4.19	-0.36	0.48
Shareholders' Equity	1,148	591.42	656.07	417.89	656.86
Total Liabilities & Equity	1,367	728.3	754.78	489.92	717.31
Total Debt	16.98	16.94	20.04	25.41	29.14
Net Cash (Debt)	984.09	481	571.86	386.93	628.31
Net Cash Growth	104.59%	-15.89%	47.80%	-38.42%	212.80%
Net Cash Per Share	9.54	5.02	6.08	4.76	8.93
Filing Date Shares Outstanding	106.33	96.81	95.28	93.59	80.92
Total Common Shares Outstanding	106.24	96.38	94.83	81.89	80.46
Working Capital	1,102	544.25	654.72	413.92	654.05
Book Value Per Share	10.81	6.14	6.92	5.10	8.16
Tangible Book Value	1,148	591.42	656.07	417.89	656.86
Tangible Book Value Per Share	10.81	6.14	6.92	5.10	8.16
Machinery	-	-	-	5.12	4.79
Leasehold Improvements	-	-	-	1.24	1.24

Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q